Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France.
Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.
J Assist Reprod Genet. 2021 Jun;38(6):1311-1321. doi: 10.1007/s10815-021-02249-3. Epub 2021 Jun 4.
To identify the FSH receptor (FSHR) variant and efficacy of in vitro maturation (IVM) in a 28-year-old woman with secondary amenorrhea, primary infertility, and ovarian resistance to FSH, and to analyze the genotype-to-phenotype relationship in cases of FSHR mutation for the development of an IVM algorithm for use in patients with gonadotropin resistance syndrome (GRS).
Oocytes retrieved after menstruation induction with norethisterone, followed by daily estrogen and an ovulatory trigger, underwent IVM, ICSI, and culture in a time-lapse (TL) incubator. Embryo transfers were performed on day 2, and after thawing on day 5. Genes associated with disorders of sex development were sequenced for both the patient and her parents. All reported cases of FSHR mutation were analyzed to investigate genotype/phenotypic relationships.
After ovum pickup, seven of 16 oocytes matured and all fertilized. After unsuccessful day 2 transfer, our patient delivered with a thawed day 5 blastocyst, the sole embryo without abnormal TL phenotypes. Genetic analysis revealed a new composite heterozygous FSHR variant. Analysis of our patient case with published cases of GRS revealed associations among FSHR variant genotype, location on the FSHR, functionality of tested variants, and type of amenorrhea. An algorithm for application of IVM for GRS patients was developed.
We report two novel variants of the FSHR. Although IVM successfully matured some oocytes, only one resulted in an embryo with normal TL phenotypes. We recommend FSHR genetic testing in GRS patients, which will help guide their suitability for IVM.
鉴定一位继发闭经、原发不孕且卵巢对 FSH 抵抗的 28 岁女性的 FSH 受体(FSHR)变异体和体外成熟(IVM)的疗效,并分析 FSHR 突变病例的基因型-表型关系,为开发用于促性腺激素抵抗综合征(GRS)患者的 IVM 算法。
在使用炔诺酮诱导月经后,经每日雌激素和排卵触发剂处理,进行 IVM、ICSI 和在时间 lapse(TL)孵育箱中培养。胚胎转移在第 2 天进行,在第 5 天解冻后进行。对患者及其父母的性别发育障碍相关基因进行测序。分析所有报告的 FSHR 突变病例,以研究基因型/表型关系。
在取卵后,16 个卵子中有 7 个成熟,且均受精。第 2 天的胚胎转移不成功后,我们的患者在第 5 天解冻时移植了一个具有正常 TL 表型的囊胚,这是唯一没有异常 TL 表型的胚胎。遗传分析显示存在一种新的复合杂合 FSHR 变体。对我们的患者病例和已发表的 GRS 病例进行分析发现,FSHR 变体基因型、FSHR 位置、已测试变体的功能和闭经类型之间存在关联。开发了用于 GRS 患者 IVM 的应用算法。
我们报告了两种新的 FSHR 变体。尽管 IVM 成功成熟了一些卵子,但只有一个卵子产生了具有正常 TL 表型的胚胎。我们建议对 GRS 患者进行 FSHR 基因检测,这将有助于指导他们是否适合 IVM。